200 Participants Needed

Behavioral Treatment for Insomnia in PTSD

(BBTI & PTSD Trial)

SM
JH
Overseen ByJoy Huggins, MA
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: VA Office of Research and Development
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This study will investigate treatments for insomnia in Veterans who have posttraumatic stress disorder (PTSD). The purpose of this study is to compare a brief behavioral treatment for insomnia (BBTI) to a treatment that helps promote relaxation (progressive muscle relaxation training or PMRT). The investigators will examine improvements in psychosocial functioning and insomnia severity. The investigators will also examine whether treatment gains last over time and whether suicidal ideation decreases following insomnia treatment.

Will I have to stop taking my current medications?

No, you won't have to stop taking your current medications, but you must be stable on them for at least one month and not change them during the study.

What data supports the effectiveness of the treatment for insomnia in PTSD?

Research shows that Brief Behavioral Treatment for Insomnia (BBTI) is effective in improving sleep and reducing trauma-related nightmares in veterans, similar to longer cognitive-behavioral therapy. It also enhances psychosocial functioning and is recommended as a first-line treatment for insomnia in military settings.12345

Is Brief Behavioral Treatment for Insomnia (BBTI) safe for humans?

BBTI is generally considered safe for humans, as it is a non-drug treatment focusing on behavioral changes to improve sleep. It has been used successfully in various populations, including veterans, without significant safety concerns reported.24567

How is the treatment for insomnia in PTSD different from other treatments?

The Brief Behavioral Treatment for Insomnia (BBTI) is unique because it requires fewer sessions (only 4) compared to traditional cognitive-behavioral therapy for insomnia (CBT-I), making it a quicker option for treating insomnia. It also specifically targets trauma-related nightmares, which are common in PTSD, and has been shown to improve psychosocial functioning in veterans.13458

Research Team

SM

Shira Maguen, PhD

Principal Investigator

San Francisco VA Medical Center, San Francisco, CA

Eligibility Criteria

Veterans aged 18-75 with PTSD and insomnia can join this study. They must have stable medication for at least a month and not plan changes during the trial. Those in psychotherapy should be steady in their treatment, but cannot start new therapies targeting insomnia or PTSD until after the trial.

Inclusion Criteria

I am a military veteran aged between 18 and 75.
Veterans who meet DSM-5 Criteria for Insomnia Disorder
I have been in psychotherapy for over a month and won't stop during the trial.
See 7 more

Exclusion Criteria

Veterans with unstable housing
Veterans who work night or rotating shifts
Veterans who are pregnant
See 5 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either Brief Behavioral Treatment for Insomnia (BBTI) or Progressive Muscle Relaxation Training (PMRT) over 4 sessions

4 weeks
4 sessions (video and phone-based)

Follow-up

Participants are monitored for psychosocial functioning and insomnia severity, with additional follow-up for the BBTI group

6 months
Follow-up assessments at 6 months for BBTI group

Treatment Details

Interventions

  • Brief Behavioral Treatment for Insomnia (BBTI)
  • Progressive Muscle Relaxation Training (PMRT)
Trial OverviewThe study compares Brief Behavioral Treatment for Insomnia (BBTI) to Progressive Muscle Relaxation Training (PMRT) in improving sleep and psychosocial functioning among veterans with PTSD. It also looks at long-term benefits and effects on suicidal thoughts.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: BBTIExperimental Treatment1 Intervention
Participants in this arm will receive 4 sessions (30-60 minutes) of a brief behavioral treatment for insomnia (BBTI). Relaxation techniques are not a component of BBTI.
Group II: PMRTActive Control1 Intervention
Participants in this arm will receive 4 sessions (30-60 minutes) of progressive muscle relaxation training (PMRT).

Brief Behavioral Treatment for Insomnia (BBTI) is already approved in United States for the following indications:

🇺🇸
Approved in United States as BBTI for:
  • Insomnia
  • Insomnia comorbid with psychiatric, medical, or sleep disorders
  • Posttraumatic Stress Disorder (PTSD)

Find a Clinic Near You

Who Is Running the Clinical Trial?

VA Office of Research and Development

Lead Sponsor

Trials
1,691
Recruited
3,759,000+

Findings from Research

The study involving 91 military veterans found that Brief Behavioral Treatment for Insomnia (BBTI) significantly reduced trauma-related nightmares compared to an active control group using progressive muscle relaxation therapy, although these reductions were not maintained at a 6-month follow-up.
Neither BBTI nor progressive muscle relaxation therapy had an effect on nontrauma-related bad dreams, indicating that while BBTI may help with trauma-related nightmares, its impact on other types of bad dreams remains unclear.
Brief behavioral treatment for insomnia decreases trauma-related nightmare frequency in veterans.Ranney, RM., Gloria, R., Metzler, TJ., et al.[2023]
Brief Behavioral Treatment for Insomnia (BBTI) is a concise, four-session therapy designed to overcome barriers to accessing traditional cognitive-behavioral therapy for insomnia (CBTI), making it easier for clinicians to deliver.
BBTI has shown efficacy in treating older adults with insomnia, providing a practical alternative to standard CBTI, which is limited by a shortage of trained clinicians.
Clinical management of insomnia with brief behavioral treatment (BBTI).Troxel, WM., Germain, A., Buysse, DJ.[2022]
A brief behavioral treatment for insomnia (BBTI) was tested against cognitive behavioral therapy for insomnia (CBTI) in a study involving 63 veterans, showing that both treatments significantly reduced insomnia severity, but BBTI's effectiveness was inconclusive compared to CBTI.
While CBTI showed a greater reduction in insomnia severity, the difference was not statistically significant enough to declare BBTI inferior, suggesting that BBTI could be a viable alternative for veterans seeking shorter treatment options.
Brief Behavioral Treatment for Insomnia vs. Cognitive Behavioral Therapy for Insomnia: Results of a Randomized Noninferiority Clinical Trial Among Veterans.Bramoweth, AD., Lederer, LG., Youk, AO., et al.[2023]

References

Brief behavioral treatment for insomnia decreases trauma-related nightmare frequency in veterans. [2023]
Clinical management of insomnia with brief behavioral treatment (BBTI). [2022]
Brief Behavioral Treatment for Insomnia vs. Cognitive Behavioral Therapy for Insomnia: Results of a Randomized Noninferiority Clinical Trial Among Veterans. [2023]
Survey of Resources in Behavioral Sleep Medicine Across the Department of Defense, Defense Health Agency. [2023]
Brief behavioral treatment for insomnia improves psychosocial functioning in veterans: results from a randomized controlled trial. [2021]
Reducing Barriers to Behavioral Treatments for Insomnia: A Qualitative Examination of Veterans' Perspectives of BBTI. [2022]
Brief behavioral treatment for patients with treatment-resistant insomnia. [2020]
The impact of prolonged exposure on sleep and enhancing treatment outcomes with evidence-based sleep interventions: A pilot study. [2021]